Pharmaceutical

AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson’s

At AD/PD 2025, Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early Parkinson’s disease (PD).

Apr 4, 2025 - 06:00
AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson’s
At AD/PD 2025, Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early Parkinson’s disease (PD).
Read the original article

Tags:

Previous Article

IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility

Next Article

ABPI calls on UK Government to resolve “VPAG crisis”

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: White House touts efforts to stem cancer drug shortages

STAT+: White House touts efforts to stem cancer drug sh...

Sep 12, 2023

Italfarmaco secures FDA approval for Duchenne muscular dystrophy drug

Italfarmaco secures FDA approval for Duchenne muscular ...

Mar 24, 2024

Gail Wilensky on the Geisinger deal, the earnings bonanza, and medical credit cards proliferate

Gail Wilensky on the Geisinger deal, the earnings bonan...

May 9, 2023